Thursday, December 16, 2021 11:23:21 AM
Histogen Announces $3.5 Million Private Placement
8:00 am ET December 16, 2021 (Globe Newswire)
"Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function, announced today that it has entered into securities purchase agreements with certain institutional and accredited investors to issue, in a private placement, 8,235,297 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 8,235,297 shares of common stock, at a purchase price of $0.425 per share of common stock (or pre-funded warrant) and associated warrant, for expected gross proceeds to Histogen of approximately $3.5 million, before deducting placement agent fees and other offering expenses payable by the Company. The warrants have an exercise price of $0.425 per share of common stock, will be exercisable commencing six months and one day following the date of issuance for a period of five and one-half years from the date of issuance.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the private placement.
The closing of the private placement is expected to occur on or about December 20, 2021, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the private placement for working capital and general corporate purposes."
Recent HSTO News
- Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering • GlobeNewswire Inc. • 04/18/2024 09:29:15 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/04/2024 06:21:25 PM
- Histogen Announces Second Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 12/14/2023 09:15:00 PM
- Histogen Announces Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 12/05/2023 09:05:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/16/2023 09:07:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/18/2023 08:05:05 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/04/2023 08:08:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:05:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:06:41 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM